LRRC32, Human, 重组蛋白 (hFc) TMPJ-00364
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | TMPJ-00364 | ¥22,200.00 | 询底价 |
10 μg | TMPJ-00364 | ¥650.00 | 询底价 |
50 μg | TMPJ-00364 | ¥1,970.00 | 询底价 |
500 μg | TMPJ-00364 | ¥14,800.00 | 询底价 |
Product Introduction
Bioactivity
英文名: LRRC32 Protein, Human, Recombinant (hFc)
描述: Leucine Rich Repeat Containing 32 (LRRC32), also known as Glycoprotein A Repetitions Predominant (GARP), has been postulated as a novel surface marker of activated T(regs). LRRC32 binds directly to the TGF-beta latency associated peptide (LAP) and tethers latent TGF-beta on the surface of activated Treg cells. The presentation of TGF-beta on Tregs contributes to their ability to suppress naïve T cell proliferation. LRRC32 is widely expressed during embryogenesis and on adult platelets. Human LRRC32 is identified as a lineage specific key receptor for human T cells.
存储条件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month
LRRC32, Human, 重组蛋白 (hFc) TMPJ-00364信息由TargetMol中国为您提供,如您想了解更多关于LRRC32, Human, 重组蛋白 (hFc) TMPJ-00364报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途